Results 21 to 30 of about 9,824 (158)
Background. Idiopathic Thrombocytopenic Purpura is one of the most common acquired blood-clotting disorders in adolescents. This disease is characterized by an increased risk of developing concomitant gynecological pathologies, such as abnormal uterine ...
Elena V. Sibirskaya+3 more
doaj +1 more source
Multiple splenic artery aneurysms in a patient with idiopathic thrombocytopenic purpura: A case report, brief literature review and discussion.
David Busel+3 more
doaj +1 more source
Abstract Background Cardiac surgery on cardiopulmonary bypass (CPB) may alter platelet (PLT) function causing bleeding. The goal of this study is to evaluate the hemostatic effect of PRT‐PLTs compared to untreated PLTs stored in platelet additive solution (PAS) following transfusion in bleeding patients undergoing cardiac surgery on CPB.
Magali J. Fontaine+11 more
wiley +1 more source
ABSTRACT Xenotransplantation is becoming an emerging field of interest for the treatment of end‐stage heart disease. In fact, the shortage of human heart donors in European countries requires the increasing investigation of alternative strategies such as heart xenotransplantation.
Nicola Pradegan+6 more
wiley +1 more source
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura
Rituximab 375 mg/m2 weekly for four weeks has significant activity in patients with immune thrombocytopenia. We evaluated the activity of lower dose rituximab (100 mg iv weekly for 4 weeks) in 28 adults with idiopathic thrombocytopenic purpura.
Francesco Zaja+18 more
doaj +1 more source
Background: Idiopathic thrombocytopenic purpura , a disorder characterized by autoantibody mediated platelets destruction causing decreased number of circulating platelets manifest as bleeding tendency.
Sawsan S. Abbas, Tariq M. Hadi
doaj
Síndrome de Evans - presentación atípica de un linfoma raro
Evans Syndrome is a rare autoimmune condition characterized by two or more cytopenias, usually autoimmune haemolytic anaemia and immune thrombocytopenic purpura. It can be primary/idiopathic or secondary to other diseases.
Catarina Teles Neto+5 more
doaj +1 more source
This review seeks to provide a thorough synthesis of the existing literature on the role of thrombopoietin receptor agonists in the treatment of primary and secondary immune thrombocytopenia, with particular emphasis on the compound Hetrombopag. Abstract Immune thrombocytopenia (ITP) is a rare autoimmune disorder characterized by a platelet count below
Jiaqi Hu+8 more
wiley +1 more source
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura.
BACKGROUND The pathogenesis of chronic idiopathic thrombocytopenic purpura (ITP) involves antibody-mediated platelet destruction and reduced platelet production.
J. Bussel+12 more
semanticscholar +1 more source
Abstract The clinical and immunophenotypic attributes of reactive γδ T‐cell expansions are less well characterized than their malignant counterparts, which can pose diagnostic challenges. This study aims to investigate the characteristics and long‐term clinical outcomes of reactive γδ T‐cell expansions.
Hamza Tariq+6 more
wiley +1 more source